News

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...
The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...
As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...
New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...
The notion that we can simultaneously demand expedited approvals while gutting the agency is misguided.
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Artificial colors will be removed by the end of this year from Lay's and Tostitos brands, according to PepsiCo's chairman and ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment for a rare genetic condition that typically affects boys, the drug developer ...
FDA Commissioner Marty Makary stated that the agency has several actions planned to phase out the use of synthetic dyes in ...